Although different studies classify breast cancer cell lines into different categories, the most general subtyping is based on the expression of three immunohistochemistry markers, ER, progesterone receptor (PR) and the human epidermal growth factor receptor 2 (HER2).15 This evidence concerns the gene ERBB2 and breast cancer.